Salcaprozate Sodium (SNAC) -ECHEMI
25 Inquiries
203787-91-1
Pharmaceutical Grade
Any China Port
1 kgs/bag
2024-12-06
API,Intermediate
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceSalcaprozate Sodium is the sodium salt form of salcaprozate, an oral absorption promoter. Salcaprozate sodium may be used as a delivery agent to promote the oral absorption of certain macromolecules with poor bioavailability such as insulin and heparin.
It is a white to off-white crystalline powder, and its solubility in water is approximately 33 mg/mL.
Salcaprozate Sodium (SNAC) is a synthetic N-acetylated amino-acid derivative of salicylic acid. SNAC is a weak acid that display amphiphilicity and surface activity. It was discovered as part of a screen to identify carrier-based PEs that could “chaperone” poorly permeable payloads across the intestine. This compound is the most extensively tested carrier and the only PE approved in an oral formulation designed to improve oral BA, albeit with a small molecule, cyanocobalamin/SNAC. In other preclinical studies, it also improved intestinal permeation of peptides (salmon calcitonin (sCT) and insulin), along with poorly permeable small molecules (e.g., cromolyn). SNAC was tested in many formats: taste-masked liquids, tablets, and soft gelatin capsules. Similar to C10, SNAC can be blended with the active pharmaceutical ingredient (API) using conventional processes, which makes manufacturing uncoated oral tablet dosage forms economic and relatively easy to scale[1].Basic Info-
Product Name:
Salcaprozate Sodium
Other Name:sodium,8-[(2-hydroxybenzoyl)amino]octanoate;Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, monosodium salt;SNAC,sodium 8-[(2-hydroxybenzoyl)amino]octanoate;Salcaprozate sodium;Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, sodium salt;2,5-Furandione,3-chlorodihydro-,(7R)-;N-[8-(2-Hydroxybenzoyl)amino]caprylic acid, disodium salt;Chlorotoluron Impurity 3
CAS No.:203787-91-1
Molecular Formula:C15H22NNaO4
InChIKeys:OBKUJEVXEMKQMJ-UHFFFAOYSA-N
Molecular Weight:303.33
Exact Mass:301.12900240
EC Number:231-019-4
UNII:1YTW0422YU
DSSTox ID:DTXSID50174306
NCI Thesaurus Code:C75026
Color/Form:White to Off-White
Categories:
Characteristics-
Melting Point:
183 - 185°C
Critical Temperature & Pressure:Inert atmosphere,Room Temperature
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30 days
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.

Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.

Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History25 Inquiries
Country Product Purchase Quantity Date Posted
India
Salcaprozate Sodium
1 KG Feb 13, 2026
India
Salcaprozate sodium
1 KG May 8, 2024
Tunisia
Salcaprozate de sodium (SNAC)
1 MT May 4, 2026
India
Salcaprozate Sodium
1 KG Jul 20, 2026
Italy
Sodium Salcaprozate (SNAC)
250 G Apr 17, 2026
Pakistan
SALCAPROZATE SODIUM SNAC
450 KG Apr 10, 2026
United States
Salcaprozate Sodium
500 KG Feb 18, 2026
United States
Salcaprozate Sodium/ SNAC 99%
10 KG Feb 13, 2026
Pakistan
SALCAPROZATE SODIUM
500 KG Feb 11, 2026
Pakistan
SALCAPROZATE SODIUM
600 KG Jan 28, 2026
United States
Salcaprozate Sodium
1 KG Nov 26, 2025
Bangladesh
Salcaprozate Sodium-GMP
500 KG Nov 21, 2024
United States
Salcaprozate Sodium
10 KG Sep 14, 2024
Russia
salcaprozate sodium
20 KG Jan 18, 2024
United Kingdom
Salcaprozate Sodium -----the supporting excipient of Semaglutide
5 KG Nov 17, 2023
Pakistan
SALCAPROZATE SODIUM
180 KG Jul 20, 2026
United Kingdom
Salcaprozate Sodium
1 MT Jul 17, 2026
Pakistan
SALCAPROZATE SODIUM
50 KG Jun 5, 2026
United States
Salcaprozate Sodium
50 KG Feb 27, 2026
Pakistan
Salcaprozate Sodium
5 KG Jan 9, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Semaglutide
Pharmacy Grade / 99%
-
-
-
-
Bis(trichloromethyl) carbonate 99.0% Powder Echemi
Industrial Grade / 99.0%
-
-
-
-
Tenofovir disoproxil fumarate
Pharmaceutical Grade / 99%
-
-
-
-
5-Azacytidine
Pharmaceutical Grade / 99%
-
-
-
-
PF-07321332 (Paxlovid) intermediates 99.0% Powder Echemi
Pharmaceutical Grade / 99.0%
-
-
-
-
Sodium Ethoxide
Pesticide Grade / 99%
-